ingredients and adjuvant for the purpose of adulteration. It is estimated that the economic loss due to drug-counterfeiting is 75 billion US dollars in 2010. Due to counterfeiting‚ pharmaceutical companies are deprived from their profit of developing and marketing the drugs. This may in turn lead to loss of interest by the pharmaceutical companies to develop more new and effective drugs in the
Premium Pharmacology Pharmaceutical drug Authentication
of the Pharmaceutical sector In the year 2004‚ the global economy experienced a momentum. After the dot.com bubble and the 9/11 terrorist attacks‚ the economy slowed down‚ especially in the USA. The American economy‚ which was the greatest market for the pharmaceutical industry‚ suffered an economic recession from 2001 to 2003. However‚ in 2004 the tax cuts and the lower interest rates stimulated a robust expansion in that country. Particularly‚ the worldwide sales in pharmaceutical products
Premium Pharmaceutical industry
Access to essential medicines is therefore a right recognized as universal by the international community. But between what must be and what is‚ there is an immeasurable gap here‚ partly linked to the functioning of the pharmaceutical market. 3.4.2 Economic barriers to access to essential medicines Two major obstacles stand in the way of the equitable distribution of essential medicines: the problem of availability of medicines and their accessibility.93 • The availability
Premium Medicine Drug Pharmacology
decision‚ under what terms should Cambridge Laboratories move forward with the proposal from CPL? These questions are central to the firm because proteomics markers have the potential to become a major stream of revenue for Cambridge Labs. Pharmaceutical companies are starting proteomics programs and this market is projected to grow to $6 billion in 2005. Laboratory services have the potential to
Premium Strategic management Pharmaceutical industry
The Headaches of GlaxoWellcome ( Migraine medicine is a key growth area for Glaxo Wellcome Inc. (Glaxo); a Britain-based pharmaceutical company with global operations.[1] Glaxo’s primary business is to market prescription products to physicians and healthcare providers. Glaxo was the first pharmaceutical company to manufacture and market a revolutionary new class of prescription migraine medications called “triptans”. Triptans‚ which Glaxo launched in 1993‚ are a class of medications that work
Premium Pharmaceutical industry Marketing
News of the latest advancements in strategies and treatment against many rare diseases comes out of the pharmaceutical company named Amicus Therapeutics. Based in Cranbury‚ New Jersey‚ with a second research facility in Southern California‚ the company is making gains in the pharmaceutical industry on the heel of announcements that the Food and Drug Administration (FDA) is planning to accept a New Drug Application (NDA) for the new drug Migalastat which was developed by Amicus Therapeutics. An
Premium Medicine Pharmacology Health care
has got tremendous Research and Development application in Industry and moreover it has the ability to adjudicate various queries in the field of pharmaceutical sciences. Out of my own volition I have chosen Pharmaceutical Sciences‚ which offers ample scope for research activities and these parallels with my aspiration of a M.S. Degree. Pharmaceutical Sciences is considered with the study of the scientific study of the composition‚ properties‚ and activities of substances‚ Drugs and the changes
Premium Pharmacology Science Pharmacy
in key growing therapeutic areas and focus on delivering patient-centric‚ innovative therapies. We seek strong‚ long-term relationships that fit our goals and offer a shared vision “ * Company Background: Pfizer is a research-based global pharmaceutical company. The company discovers‚ develops‚ manufactures and markets medicines for humans and animals‚ as well as consumer products. In order To maximize new opportunities in biomedical research‚ and bring more innovative
Premium Pharmaceutical industry Generic drug
Danish Parvez Ahmed Saeed Khan Chandni Kumari Anum Ali Junejo Executive Summary This is a research on GlaxoSmithKline a pharmaceutical concern has been conducted to primarily understand two aspects. First is to comprehend the current strategy of the company and second is to suggest an apt strategy to the company after analyzing the conditions of the pharmaceutical industry and the political‚ social and legal environment at large. The report would
Premium Financial ratio Financial ratios Pharmaceutical industry
CORPORATE STRATEGY 3E LYNCH Pearson Education November 2002 |Case Title |Source‚ Number‚ |Geographical and Industry |Case Decision Issue | | |Length‚ Teaching Note|Setting‚ Company Size‚ | | | | |Timeframe | | |Chapter 1
Premium Pharmaceutical industry